Drugs Made In America Acquisition DMIIR
NASDAQ DMIIR
$0.07 -0.01 (-7.04%)
As of: Sep 2, 2026 · 12:48 PM EDT

Drugs Made In America Acquisition (DMIIR) Non-Current Assets (2024 - 2026)

Drugs Made In America Acquisition (DMIIR) posted quarterly Non-Current Assets of $504.9 million for Q4 2025, up 643545.94% year-over-year from N/an in Q4 2024, and up 0.96% quarter-over-quarter from $500.1 million in Q3 2025.

Analysis

Drugs Made In America Acquisition (DMIIR) Non-Current Assets (2024 - 2026) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has reported Non-Current Assets for 2 consecutive years, with $504.9 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Non-Current Assets rose 643545.94% year-over-year to $504.9 million; the TTM figure through Dec 2025 stood at $504.9 million (up 643545.94% YoY), while the FY2025 annual figure was $504.9 million, up 643545.94% from the prior year.
  • Non-Current Assets improved to $504.9 million in Q4 2025 per DMIIR's latest filing, from $500.1 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $504.9 million in Q4 2025 and bottomed at $78449.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Cluster Group Holdings 8.00 Bn 8.00 Bn - -
2 Agriculture & Natural Solutions Acquisition 853.42 Mn 853.17 Mn - 376.71 Mn
3 K&F Growth Acquisition 836.15 Mn 836.15 Mn - 305.19 Mn
4 Armada Acquisition 666.23 Mn 666.18 Mn - 241.16 Mn
5 Pioneer Acquisition I 652.74 Mn 652.27 Mn - 262.91 Mn
6 Oxley Bridge Acquisition 652.11 Mn 652.11 Mn - 260.52 Mn
7 Titan Acquisition 651.43 Mn 941.85 Mn - 290.67 Mn
8 GSR IV Acquisition 622.22 Mn 622.22 Mn - 236.76 Mn
9 Launch One Acquisition 618.70 Mn 618.70 Mn - 249.81 Mn
10 Drugs Made In America Acquisition 5.10 Mn 5.10 Mn - 513.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 513.88 Mn
Dec 31, 2025 504.93 Mn
Sep 30, 2025 500.11 Mn
Dec 31, 2024 78,449.00